NASDAQ · QTTB
Q32 Bio Inc.
$8.67-$0.20 (-2.22%)
Q32 Bio Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.24% below the high.
Loading market information…
NASDAQ · MDVL · USD
Stock price, earnings
Quote as of Feb 12, 2024, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
MedAvail Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.39% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow MedAvail Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
MedAvail Holdings, Inc. is a pioneer in tech-driven retail pharmacy solutions, focusing on both the technology itself and related services. The company designs and markets a range of innovative offerings, including self-service pharmacy units, mobile applications, interactive kiosks, and drive-thru services, all operating across the United States and Canada. Its operations are divided into two main areas: Retail Pharmacy Services and Pharmacy Technology. A flagship product, the MedCenter system, facilitates on-site prescription dispensing in various environments such as medical clinics, retail stores, and employer sites, or any location desiring convenient, integrated pharmacy access. Crucially, it incorporates a secure audio-visual link to a licensed pharmacist, enabling patients to receive their medications directly while benefiting from real-time professional guidance and supervision. MedAvail also manages its own retail pharmacy platform, known as SpotRx. As of the close of 2021, the company had installed 81 MedCenter kiosks. MedAvail Holdings, Inc. maintains its headquarters in Mississauga, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:49 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Mar 24, 2022 |
| -$19.00-11.76% vs estimate |
| $7.28M+14.11% vs estimate |
| Q3 2021 | Nov 8, 2021 | -$17.00-6.25% vs estimate | $5.79M+4.74% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$8.67-$0.20 (-2.22%)
Q32 Bio Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.24% below the high.
$8.50+$0.50 (+6.25%)
Eiger BioPharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.88% below the high.
$5.13+$0.20 (+3.96%)
Palatin Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.47% below the high.
$0.00$0.00 (0.0%)
RVL Pharmaceuticals plc’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
$0.04-$0.01 (-13.39%)
Aravive, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.37% below the high.
$0.08-$0.02 (-15.9%)
Aspira Women's Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.74% below the high.
€0.03-€0.00 (-8.98%)
Biophytis S.A.’s quoted price sits in the lower half of its reported 52-week range, 81.0% below the high.
$0.00+$0.00 (+200.0%)
Affimed N.V.’s quoted price sits in the lower half of its reported 52-week range, 98.35% below the high.
